Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Onapristone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 13/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 11/20 | 1.00 |
| ▸ | AR | P10275 | 8/20 | 1.00 |
| ▸ | NR3C2 | P08235 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.69 |
| ▸ | ESR1 | P03372 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.69 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.69 |
| ▸ | THPO | P40225 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Onapristone SCHEMBL8740 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL1649697 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL14666146 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL9170610 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL6670566 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL24910667 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL9558688 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL9558898 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL21740378 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 | |
| Onapristone SCHEMBL14870640 | 1.00 | PGR (1.00) | PGRNR3C1ARNR3C2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0184471-B1 | PRODUCT CONTAINING AN ANTIPROGESTOMIMETIC AND A UTEROTONIC SUBSTANCE | ROUSSEL-UCLAF (FR) | 1990-11-14 | — | — | EP | claimed |
| EP-0184471-A1 | Product containing an antiprogestomimetic and a uterotonic substance | ROUSSEL-UCLAF (FR) | 1986-06-11 | — | — | EP | claimed |
| US-4536401-A | ANTIPROGESTATION AND ANTIMINERALOCORTICORD EFFECTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | claimed |
| WO-2021184021-A1 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING PMP22 | CODIAK BIOSCIENCES, INC. (US) | 2021-09-16 | — | — | WO | disclosed |
| CN-113286608-A | Chimeric Antigen Receptor (CAR) groups | 圣安娜儿童癌症研究中心 | 2021-08-20 | — | — | CN | disclosed |
| US-5089635-A | Antiprogesterone, antiglucocorticoids | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| EP-0184471-B1 | PRODUCT CONTAINING AN ANTIPROGESTOMIMETIC AND A UTEROTONIC SUBSTANCE | ROUSSEL-UCLAF (FR) | 1990-11-14 | — | — | EP | disclosed |
| EP-0254670-B1 | 11-BETA-(4-ISOPROPENYLPHENYL)-ESTRA-4,9-DIENE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-11-15 | — | — | EP | disclosed |
| EP-0190759-B1 | 11-BETA PHENYL GONANES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-08-30 | — | — | EP | disclosed |
| US-4829060-A | ANTIGLAUCOMA | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-05-09 | — | — | US | disclosed |
| EP-0190759-A2 | 11-Beta phenyl gonanes, their preparation and pharmaceutical compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-08-13 | — | — | EP | disclosed |
| US-4536401-A | ANTIPROGESTATION AND ANTIMINERALOCORTICORD EFFECTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |